| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GLDD | Common Stock | Tax liability | $7,752 | -891 | -6.3% | $8.70 | 13,336 | 17 Mar 2025 | Direct | |
| transaction | GLDD | Common Stock | Award | +2,159 | +16% | 15,495 | 17 Mar 2025 | Direct | F1 | ||
| transaction | GLDD | Common Stock | Tax liability | $5,142 | -591 | -3.8% | $8.70 | 14,904 | 17 Mar 2025 | Direct | |
| transaction | GLDD | Common Stock | Tax liability | $3,967 | -456 | -2.7% | $8.70 | 16,379 | 17 Mar 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares awarded pursuant to satisfaction of performance conditions per the terms of Mr. Bayer's performance-based restricted stock units granted on March 15, 2024. |
| F2 | This filing adds 1,931 shares of Common Stock acquired under the Company's Employee Stock Purchase Program. |